Trial intelligence / Profile preview

Effect of serotonin transporter gene polymorphisms on gastrointestinal intolerance to metformin in Thai diabetic patients

TCTR20220718001Completed

Sponsor
Chulalongkorn University
Start
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

Single-arm trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Chulalongkorn University. Primary endpoint: Association between 5-HTTLPR and rs25531 polymorphisms and gastrointestinal intolerance to metformin. Started Apr 2022; status: completed.

02

Drugs

metformin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on TCTR20220718001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20220718001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call